During the 54th Legislature, first regular session 2019, Senate bill 1062 amended A.R.S. §32-3226 to allow licensees, who choose their residential address as their address of record, to opt out of the public disclosure of their address of record. For your convenience, additional information regarding this law can be found by reading A.R.S. § 32-3226. Please visit the Arizona State Board of Dental Examiners’ website and complete the Address Change Form to opt out of the public disclosure of your address of record if you have chosen your residential address as your address of record.
Electronic Prescribing of Controlled Substances
Beginning January 1, 2020, a Schedule II controlled substance that is an opioid may be dispensed only with an electronic prescription order as prescribed by federal law or regulation. This means that Schedule II opioid prescriptions will not be dispensed by a written prescription. Please visit the Arizona State Board of Pharmacy's website for more information. Specifically, please review the frequently asked questions. You may also wish to watch this quick 11-minute video regarding the new law on electronic prescribing of controlled substances.
A.R.S. §§ 15-1756 and 32-3248.02 impose obligations on all students attending medical programs in state that make them eligible for DEA registration to complete a minimum three hours of opioid related clinical education hours and on all healthcare professionals who hold an active Drug Enforcement Administration certifications to complete a minimum three hours of opioid-related, substance-use disorder related or addiction related continuing medical education (“CME”) as part of any continuing education requirements for renewal. The Board will begin requiring its licensees to begin meeting the CME requirement in the 2018-2019 renewal cycle.